Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa

Risultati finali

Project webpage
Project social media accounts

Project social media accounts established

Pubblicazioni

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica.

Autori: Nasrin Masoudzadeh; Malin Östensson; Josefine Persson; Vahid Mashayekhi Goyonlo; Christopher Agbajogu; Yasaman Taslimi; Reza Erfanian Salim; Farnaz Zahedifard; Amir Mizbani; Housein Malekafzali Ardekani; Bronwyn M. Gunn; Bronwyn M. Gunn; Sima Rafati; Ali M. Harandi; Ali M. Harandi
Pubblicato in: Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020), Numero 10, 2020, ISSN 2045-2322
Editore: Nature Publishing Group
DOI: 10.1038/s41598-020-72671-7

Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection.

Autori: Weidong Zhang; Weidong Zhang; Loc Le; Loc Le; Gul Ahmad; Adebayo J. Molehin; Adebayo J. Molehin; Arif J. Siddiqui; Workineh Torben; Souvik Karmakar; Juan U. Rojo; Souad Sennoune; Souad Sennoune; Samara Lazarus; Samara Lazarus; Sabiha Khatoon; Sabiha Khatoon; Jasmin Freeborn; Jasmin Freeborn; Justin Sudduth; Justin Sudduth; Ashraf F. Rezk; Ashraf F. Rezk; David Carey; Roman F. Wolf; Roman F. Wolf;
Pubblicato in: Frontiers in Immunology, 2020, ISSN 1664-3224
Editore: Frontiers
DOI: 10.17863/cam.54650

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica